Insider Transactions in Q4 2024 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
2,500
-9.73%
|
$185,000
$74.08 P/Share
|
|
Dec 16
2024
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+8.87%
|
$112,500
$45.28 P/Share
|
|
Dec 09
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$355,000
$71.75 P/Share
|
|
Dec 09
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|
|
Dec 09
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,250
-26.91%
|
$798,750
$71.68 P/Share
|
|
Dec 09
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+21.2%
|
$506,250
$45.28 P/Share
|
|
Dec 06
2024
|
Wayne Markowitz GM & SVP, Surgical |
SELL
Open market or private sale
|
Direct |
583
-5.79%
|
$42,559
$73.27 P/Share
|
|
Dec 06
2024
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
1,750
-5.97%
|
$127,750
$73.27 P/Share
|
|
Nov 13
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$325,000
$65.57 P/Share
|
|
Nov 13
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|
|
Nov 05
2024
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
25,000
-11.18%
|
$1,625,000
$65.91 P/Share
|
|
Oct 15
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$345,000
$69.51 P/Share
|
|
Oct 15
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|